A Holistic Bibliometric Exploration of the Evolution of Epidermodysplasia Verruciformis (EV) Research Authors: Farshid Danesh, Fatemeh Alinezhad Chamazcoti, Forough Rahimi, Saeed Bakhtiari Published: 2026 ABSTRACT Background:Epidermodysplasia Verruciformis (EV) is a rare autosomal recessive genodermatosis caused by chronic HPV infection. It leads to widespread cutaneous lesions and an increased risk of non-melanoma skin cancer. The main objective of this article is to conduct a holistic bibliometrics analysis of scientific publications, uncovering trends and citation networks related to EV (1931–2025).Materials and Methods:Data were extracted from the Web of Science Core Collection (1931–2025), and 1489 documents were retrieved. Bibliometric methods and related indicators, including country collaboration map, word co-occurrence, co-citation networks, topics, citations, and publications trends, were analyzed and visualized using the Bibliometrix package in R.Results:The document collection comprises 99 single-authored publications, with a Document Average Age (DAA) of 20.2 years (i.e., the average time elapsed between publication and the year of analysis, 2025), 5.36 authors per document, 32.15 citations per document, and a 2.09% annual growth rate. The five most frequent thematic trends are EV, deoxyri bonucleic acid (DNA), Squamous Cell Carcinoma, Renal Transplant Recipients, and Infection, with frequencies of 423, 167, 127, 121, and 100. The United States, Germany, and Great Britain have the highest numbers of citations, with 13,998, 6,476, and 4,776. “G. Orth,” “S. Jablonska,” and “M. Favre” received the highest number of citations in EV. The most influential journals are “Journal of Virology,” “Journal of Investigative Dermatology,” and “Virology”.Conclusion:Epidemiological studies on EV prevalence and high-risk human papillomavirus (HPV) types are crucial for policymakers and health planners. Interdisciplinary research, using artificial intelligence, image processing, and machine learning, can enhance research and collaboration. INTRODUCTION The history of Epidermodysplasia Verruciformis (EV), commonly known as the “Tree Man syndrome,” dates back to the early twentieth century, when Lewandowsky and Lutz first described it in 1922.[1] The first detailed clinical reports appeared around the 1920s.[234] EV, also known as Lewandowsky-Lutz syndrome, is a rare autosomal recessive genodermatosis characterized by chronic infection with specific human papillomavirus (HPV) subtypes, which leads to widespread cutaneous lesions and an increased risk of non-melanoma skin cancers.[56] The disease arises from mutations in the EVER 1/TMC6 or EVER 2/TMC8 genes that impair intrinsic immunity against beta-HPV strains. Clinically, EV manifests in childhood with polymorphic lesions ranging from flat, hypopigmented macules to verrucous plaques, primarily on sun-exposed areas. Histopathological examination reveals characteristic keratinocytic dysplasia, including blue-gray cytoplasmic swelling, koilocytosis, and hyperkeratosis.[67] EV exemplifies the intersection of genetic susceptibility and viral oncogenesis. Mutations in EVER 1/2 genes disrupt zinc homeostasis, allowing for beta-HPV persistence and SCC development. While current therapies emphasize lesion removal and photoprotection, emerging strategies aim to correct underlying immune defects.[89] The identification of new genetic mutations and deeper exploration of EV-associated HPV presence in both lesional and non-lesional skin of patients and healthy individuals may pave the way for a unified understanding of the viral contribution to cutaneous carcinogenesis.[10] Iranian news agencies first published the Tree Man news on March 26, 2025. Abdolnasir, a 35-year-old citizen from the city of Khash in Sistan and Baluchestan, has been diagnosed with EV or “Tree Man Syndrome” (https://shorturl.at/cQVxg). After reading this news of this rare disease, we were curious to conduct a holistic bibliometric study on all international scientific publications regarding this disease from its inception (1931) to May 2025. By identifying major research articles, high-impact authors, and leading institutions, researchers can gain insights into who is shaping the field and what areas are receiving the most attention.[11] This mapping is crucial for new researchers entering the field, as it allows them to locate and build upon foundational studies, while also identifying potential gaps that could benefit from further inquiry. We can also establish a clearer picture of who holds expertise in this niche area. This information can inspire future multidisciplinary collaborations that could lead to innovative diagnoses. Tracing the evolution of research themes[12] associated with EV can reveal how the understanding of the disease has developed over time. With the rise of molecular biology techniques and genomic analysis, new insights into the genetic underpinnings of EV may open avenues for targeted therapies. An analysis of historical trends may also highlight shifts in focus towards aspects like immunosuppression and organ transplantation, which are becoming increasingly relevant in the context of higher susceptibility to HPV infections in these patient populations. Understanding the existing literature and its landscape will not only illustrate where we are but also help to guide future inquiries. For instance, as EV serves as a model for beta-HPV-related cancer development, identifying under-researched areas could encourage funding institutions to allocate resources to study[1314] novel interventions or preventive strategies against HPV-related malignancies. In other words, with the results obtained from this study, researchers and research policymakers will be able to observe the status, effectiveness, and scientific production related to EV over nearly a century. It is worth noting that no bibliometric study has examined this disease internationally for nearly a century. Therefore, conducting such a study is essential. The main objective of this article is to conduct a holistic bibliometric analysis of scientific publications, uncovering trends and citation networks related to EV from 1931 to 2025. To accomplish this primary aim, it is crucial to address the following questions. RQ1. What are the trends in scientific publications, citation averages, and topics related to EV? RQ2. Which countries, journals, and authors have the most impact on EV? RQ3. What are the co-citation and word co-occurrence networks, as well as the world map of countries’ collaboration for EV? RQ4. What are the frequency distributions of the countries, affiliations, sources, authors, and words related to EV over time? MATERIALS AND METHODS The article focuses on “tree man syndrome” and employs bibliometric methods and related indicators. To extract data, the Medical Subject Headings (MeSH) database was first searched, and the preferred keywords in this thesaurus, which are EV, Lutz-Lewandowsky Disease, Lewandowsky-Lutz Disease, and Tree Man Syndrome, were selected. These keywords facilitated a comprehensive analysis of the existing literature, allowing for a clearer understanding of the research trends and the most significant contributions in the field. The bibliometric methods also enabled the identification of leading authors and institutions involved in studies on this rare dermatological condition. The advanced search section extracted data from the Web of Science Core Collection (WOSCC). Various parameters, such as keywords, author names, and publication years, were specified to narrow down relevant results. This approach ensured that the data collected was comprehensive and pertinent to the research objectives. The query for this advanced search is as follows: TS = (Epidermodysplasia Verruciformis) OR (tree man syndrome) OR (Lutz-Lewandowsky Disease) OR Lewandowsky-Lutz Disease) in WOSCC; Session: May 4, 2025; Results (1,489). The WOSCC was selected as the primary data source due to its rigorous journal selection criteria, curated by Clarivate through the Journal Citation Reports (JCR), which ensures high academic quality and global representativeness.[15] WOSCC offers extensive historical coverage, dating back to 1900, making it particularly suitable for longitudinal bibliometric analyses spanning several decades.[16] It is widely recognized as a gold standard in science mapping and bibliometric research, especially for studies aiming to trace the evolution of scientific fields over time.[17] Furthermore, the Bibliometrix R package—used for all analyses in this study—is specifically designed and optimized for data extracted from Web of Science, ensuring accurate parsing, analysis, and visualization of bibliographic records.[16] The retrieved data were stored in plain text format in batches of 500 and imported into the Bibliometrix R package (version 4.1.1-University of Naples Federico II) for analysis. All analyses were performed using custom R scripts in the R console environment (RStudio), rather than the Biblioshiny web interface, to ensure full reproducibility, enable advanced customizations, and allow integration with other R packages for data visualization and network analysis.[16] Bibliometrix, an open-source tool for comprehensive science mapping, was used to generate bibliometric indicators, co-citation networks, word co-occurrence maps, and international collaboration visualizations. While Scopus and PubMed also provide valuable coverage, particularly in biomedical domains, integrating data across multiple databases can introduce inconsistencies due to differences in indexing policies, metadata structure, and citation counting methods.[1819] Therefore, the use of a single, standardized source enhances methodological transparency, consistency, and reproducibility.[20] Given that most seminal research on EV—such as the foundational genetic and virological studies by Jablonska, Orth, and colleagues—has been published in high-impact, internationally recognized journals indexed in WOSCC (e.g., Journal of Investigative Dermatology, Journal of Virology), we believe this source adequately represents the core global scientific output on EV. Prior to analysis, data preprocessing was conducted to ensure data integrity. Duplicate records—arising from minor variations in author names, affiliations, or database indexing—were identified and removed using the deduplicatedDb function in the Bibliometrix R package.[16] This function employs a fuzzy matching algorithm based on key bibliographic fields, including title, authors, publication year, journal, volume, issue, page numbers, and DOI (when available). A manual verification of high-impact publications followed the process to prevent erroneous merging. The final dataset consisted of 1,489 unique documents, confirming the high level of consistency in the original WOSCC export. The search was conducted on May 4, 2025, in the WOSCC database. Without restricting the type of document, time, or language, 1489 documents were retrieved. The retrieved data were stored in plain text format in batches of 500 and sent to the Bibliometrix R package. Bibliometrix is an open-source tool for conducting comprehensive science mapping analyses of scientific literature. It was programmed in R to be flexible and facilitate integration with other statistical and graphical packages.[16] R package was utilized for data analysis and the creation of charts and maps. bibliometrix comprehensive. All document types were included in the analysis to ensure comprehensive coverage of the scientific literature on EV, as early case reports and communications may represent critical milestones in the development of research on rare diseases. The dataset was processed using the Bibliometrix R package,[16] which categorizes documents by type based on WOSCC metadata. While research articles and reviews constitute most of the collection, including all types aligns with recommended practices in science mapping for emerging or rare conditions, where knowledge development often begins with clinical observations. This study’s focus on the collaboration, co-citation, and keyword networks minimizes the potential bias caused by document type heterogeneity. No thresholds based on citation counts, publication year, or document type were applied during the analysis. The study adopted a comprehensive, inclusive approach to ensure the entire intellectual landscape of EV research was captured. This is especially important for rare diseases, where early or low-cited publications may be key foundational discoveries. Instead of using arbitrary filters, the analysis depended on network centrality measures (e.g., betweenness and closeness) within co-citation and co-word networks to identify the most influential contributions, enabling an objective and data-driven identification of key knowledge nodes. Author name disambiguation was performed using the author standardization function in the Bibliometrix R package,[16] which applies an automated algorithm based on name similarity (Levenshtein distance) and co-authorship patterns to identify and merge variant spellings of the same author. This was followed by manual verification for the most prolific and highly cited authors (e.g., G. Orth, S. Jablonska, M. Favre) to ensure accuracy, particularly given the long temporal scope of the dataset and historical variations in author name formatting. RESULTS Based on the data obtained for the subject area of EV from 1931 to 2025, there are 1,489 documents, with 5,267 authors contributing to their writing, published in 514 sources, and containing 29,561 references. The Document Average Age (DAA) is 20.2 years, and 99 Authors of Single-Authored Documents (ASAD), with an average of 5.36 Co-Authors per Document (CAPD). The Average Citation per Document (ACPD) is 32.15, and the international co-authorship rate is 24.45%. The Annual Growth Rate (AGR) is also 2.09%. The trends in scientific publications, citation averages, and topics related to EV From the 1930s to the 1970s, the number of published scientific publications was very few and scattered, ranging from zero to 11 documents. There has been a gradual but consistent increase since the 1980s, reaching a peak of 32 publications. With the onset of the 21st century, the growth trend accelerated, reaching 56 publications in 2017 [Figure 1]. Trends in Scientific Publications of Epidermodysplasia Verruciformis (EV) (1931-2025) From the 1930s to the beginning of the 21st century, the Mean Time Citation Per Year (MTCPY) of articles reached a maximum of 43.3 in 1997. Over the past 70 years, the highest MTCPY was recorded in 1997, 1995, and 1999. Since the 21st century, the highest MTCPY was in 2004, with 75.5. Furthermore, 2012 and 2009 received the highest MTCPY with four. This trend indicates a fluctuating interest in research topics over time, with certain years witnessing significant peaks in citation rates. Understanding these patterns can provide valuable insights into the evolving landscape of academic research and its impact on various fields. The highest citation rates were 91 and 2.81, respectively, while the lowest value occurred in 2025 [Figure 2]. Trends in Citation Averages of Scientific Publications of Epidermodysplasia Verruciformis (EV) (1931-2025) The horizontal lines in the above chart represent the time of activity for each thematic trend, and the dark blue circles indicate the years in which research related to that field peaked. Some research areas have received more attention than others. The five most frequent thematic trends are EV, DNA, Squamous Cell Carcinoma, Renal Transplant Recipients, and Infection, with frequencies of 423, 167, 127, 121, and 100, respectively. These topics, respectively, garnered the most scientific attention in their peak years, namely 2010, 2005, 2011, 2000, and 2009. Among the emerging topics that took shape in the second decade of the 21st century are Human Papillomavirus Infection, Mutation, and Human Papillomavirus. In the second decade of the 21st century, new concepts reflecting the shift in researchers’ perspectives on the molecular and viral mechanisms related to EV emerged, including “Human Papillomavirus and Mutation” and “Human Papillomavirus Infection” in 2011 and 2014 [Figure 3]. Trends in Topics of Scientific Publications of Epidermodysplasia Verruciformis (EV) (1931–2025) The Most Influential Authors, Journals, and Countries in EV The United States, Germany, and Great Britain have the highest numbers of citations, with 13,998, 6,476, and 4,776, respectively [Figure 4]. “G. Orth,” “S. Jablonska,” and “M. Favre” received the highest number of citations in this field and are considered the most effective researchers in EV [Figure 5]. The mentioned individuals are from France, Poland, and France, respectively. Additionally, the most cited journals in this field, Journal of Virology, Journal of Investigative Dermatology, and Virology, with quartiles Q2, Q1, and Q3, respectively, are from the United States. These journals play a crucial role in disseminating significant research findings and advancing knowledge in the field of EV. The contributions of these researchers and publications continue to shape the landscape of virology and dermatological studies [Figure 6]. Most Influential Countries’ Scientific Publications of Epidermodysplasia Verruciformis (EV) (1931–2025) Most Influential Authors’ Scientific Publications of Epidermodysplasia Verruciformis (EV) (1931–2025) Most Influential Journals’ Scientific Publications of Epidermodysplasia Verruciformis (EV) (1931–2025) Analysis of Keywords Co-Occurrence, Co-citation Networks, and Collaboration of Countries in the Field of EV Sixty-four countries collaborated. France, the United States, and Germany have had the most collaborations with other countries. The most frequent collaboration pairs were between France-Poland, the USA-France, and the USA-Germany, with 45, 41, and 32 collaborations, respectively. In the co-citation networks, four clusters have formed, with the highest betweenness centrality belonging to the 3rd and fourth clusters. Six authors from these clusters have a betweenness centrality above 20, indicating that the authors in these two clusters play a significant role in connecting different parts of the network. The difference among the authors in terms of closeness centrality is a low position. However, N. Ramoz, G. Orth, and S. Jablonska hold a high position that aligns with their mediating role. The findings also revealed that the co-word network consists of three clusters. The betweenness centrality of the network also indicates that EV, DNA, and Renal Transplant Recipients rank higher than other keywords and are the most prominent words of this research [Figure 7]. (a) Co-occurrence networks and (b) Co-citation, and (c) the countries’ collaboration world map of Scientific Publications of Epidermodysplasia Verruciformis (EV) (1931–2025) The Most Prolific Authors, Affiliations, Countries, Journals, and the Most Commonly Used Words in the Field of EV G. Orth has the longest and most consistent publication record, beginning in the 1960s and extending through 2025, with peak productivity during the 1980s and 1990s. S. Jablonska started publishing in the 1960s, experienced a major increase in the 1980s and 1990s, and then reduced activity after 2000. H. Pfister began publishing in the 1980s and maintained steady output until 2020. M. Favre’s work is mainly concentrated between the 1970s and 2010, with notable peaks in the 1990s. S. K. Tyring appeared in the 1990s and has remained active through 2025. J. MB. Bavinck, J. L. Casanova, P. Rady, and P. L. Rady show more recent or sporadic contributions, with activity starting in the 1990s or later. This visualization emphasizes the sustained leadership of G. Orth and S. Jablonska, as well as the rise of newer researchers in the 21st century [Figure 8]. Frequency distributions of the Authors’ Scientific Publications of Epidermodysplasia Verruciformis (EV) (1931–2025) Figure 9 shows a notable rise in productivity starting in the late 1970s, with most affiliations exhibiting minimal activity before 1980. The University of Texas System (blue line) leads in total output, exceeding 200 publications by 2025, followed by Université Paris Cité (pink line) with around 140 articles and Pasteur Network (light blue line) with about 100. Other key contributors include the University of California, San Diego (green), Stanford University (orange), and the University of Manchester (purple). The sharp increase in publication rates from the early 2000s reflects growing global interest and investment in EV research, especially in molecular virology and dermatology. This visualization emphasizes the dominant role of U.S.-based institutions, particularly the University of Texas System, in shaping the scientific landscape of EV research over the last four decades [Figure 9]. Frequency distributions of the Affiliations’ Scientific Publications of Epidermodysplasia Verruciformis (EV) (1931–2025) Figure 10 shows a steady rise in output starting in the 1960s, with little activity before 1970. A significant increase happened after 1990, especially in the 2000s. The Journal of Investigative Dermatology (blue line) leads in total output, exceeding 100 publications by 2025, followed by the British Journal of Dermatology (orange line) and Dermatologica (pink line). Other important journals include the Journal of Virology, Virology, and Archives of Dermatology. This visualization emphasizes the leading role of dermatology and virology journals in publishing EV research, with a clear shift toward higher publication rates in the 21st century, showing increased global interest and more collaboration across disciplines [Figure 10]. Frequency distributions of the Journals’ Scientific Publications of Epidermodysplasia Verruciformis (EV) (1931–2025) The United States (pink line) leads in cumulative production, surpassing 1,000 articles by 2025, followed by France (yellow line) with approximately 400 publications and Germany (blue line) with around 200. Other notable contributors include Japan (green), the United Kingdom (light blue), and Poland (orange). Research activity stayed low before the 1980s, with a significant boost starting in the 1990s and a sharp increase after 2000. The United States shows the fastest growth, especially from 2005 onward, reflecting its dominant role in EV research. This visualization emphasizes the global expansion of EV research, with the U.S., France, and Germany emerging as the main centers of scientific output over the past four decades [Figure 11]. Frequency distributions of the Countries’ Scientific Publications of Epidermodysplasia Verruciformis (EV) (1931–2025) The most frequently used term is “EPIDERMODYSPPLASIA VERRUCCIFORMIS,” which shows a sharp increase starting in the 1990s and dominates the literature by 2025, reflecting its central role as the main subject of study. “DNA” ranks as the second most common term, with steady growth beginning in the late 1980s, highlighting the growing focus on molecular genetics in EV research. “INFECTION” and “CANCER” also demonstrate notable upward trends, especially from 2000, emphasizing the increasing importance of viral pathogenesis and oncogenic outcomes [Figure 12]. Frequency distributions of the words over time of Scientific Publications of Epidermodysplasia Verruciformis (EV) (1931–2025) Other significant terms include “RENAL TRANSPLANT RECIPIENTS,” which appeared around 1990 and experienced a sharp rise after 2005, indicating increased interest in EV as a complication of immunosuppression. “SKIN” and “VIRUS” show consistent but moderate growth, highlighting the dermatological and virological aspects of the disease. “SQUAMOUS CELL CARCINOMA” emerged in the 1990s and steadily increased, aligning with the known risk of malignant transformation in EV patients. “MUTATION” and “HUMAN PAPILLOMAVIRUS” appeared later, in the 2000s, reflecting advances in understanding the genetic and viral mechanisms behind EV [Figure 12]. This visualization illustrates a clear shift in research focus from clinical descriptions to molecular biology, virology, and oncology over the past thirty years, with “EPIDERMODYSPPLASIA VERRUCCIFORMIS” and “DNA” serving as the foundational pillars of the field’s intellectual development. DISCUSSION The review of the results showed that the frequency of published articles was initially low, then gradually increased with a slow upward trend in scientific production in the field of EV. At the beginning of the 21st century, EV publications gained significant momentum. In other words, research and development in this field have attracted the attention of many researchers, universities, and countries recently, especially considering the continuous association of this disease with the occurrence of genetic mutations, infections, and kidney transplants, which aligns with the findings of Przybyszewska et al. (2017).[2] The results of the intermedial centrality also showed that phrases such as “Epidermodysplasia-Verruciformis,” “DNA,” and “Renal-Transplant Recipients” have been the most important and strategic keywords of the present study. These keywords highlight the critical areas of focus within the research, emphasizing the interplay between genetic factors and the health outcomes of individuals who have undergone kidney transplants. Further exploration of these topics could lead to significant advancements in understanding disease mechanisms and improving patient care. The analysis of thematic trends related to EV disease reveals a significant increase in scientific and research activities across various fields related to EV from 1931 to 2025. In the second decade of the twenty-first century, we are witnessing the emergence of new concepts that reflect a transformation in researchers’ perspectives on the molecular and viral mechanisms related to EV. Discovering emerging research areas is one of the most important tasks for policymakers in health science and technology, as well as EV researchers. Emerging fields and technologies provide enhanced opportunities for scientific planning in the country and across various scientific disciplines for researchers. The emergence of these concepts reflects the increasing focus of research on the role of high-risk HPV types, viral and host genetic mutations, and the carcinogenic mechanisms associated with them. The findings of Danesh and Ghavidel (2019), which utilized word co-occurrence analysis, indicated that one of the most significant clusters in HPV research is the cancers caused by this virus.[21] The countries with the highest number of citations received are the United States, Germany, and the United Kingdom. Additionally, in terms of scientific production, the United States, France, and Germany have secured the first, second, and third positions internationally in the field of EV. The results also indicate that the United States has secured the top position in terms of scientific output, effectiveness, and the abundance of articles published in journals in the field of EV. These findings are consistent with the results of Tapia et al. (2024) and Konar et al. (2022).[2223] A review of the results obtained indicates that France, the United States, and Germany have had the highest participation among other countries. Among the active countries in the EV sector, France holds a strategic position and acts as a bridge between Eastern European countries (such as Poland) and Western countries. The dominant pattern of collaboration has formed as intra-continental (Europe-Europe) and inter-continental (Europe-America). Moreover, the level of participation (Asia-Asia) and (Africa-Africa) is limited and infrequent. National and regional epidemiological studies to examine the trend of EV prevalence and the distribution of high-risk HPV types in susceptible populations are among the strategic research necessities in this field.[24] These studies can significantly assist policymakers and health planners in preventive genetic screening, estimating treatment costs, the social burden of the disease, creating early intervention protocols, and providing an operational roadmap for systematic control and intervention. The formation of multifaceted and interdisciplinary research among dermatologists, geneticists, epidemiologists, data scientists, and health information technology specialists is crucial for the development and advancement of studies, as well as for providing practical solutions in real-world settings. The integration of artificial intelligence (AI) tools for early detection of suspicious lesions, combined with statistical analyses to examine the relationship between virus types and cancer risk, offers powerful opportunities for advancing research in EV and its connection with high-risk HPV strains. Recent studies have shown that incorporating HPV genotype data into machine learning models significantly enhances the prediction of cervical intraepithelial neoplasia and cancer risk, emphasizing the importance of virus-type stratification in accurate risk assessment.[25] Moreover, AI-driven image processing techniques, including deep learning applications in cytology and colposcopy, have demonstrated strong potential for identifying precancerous and cancerous lesions with high accuracy. These interdisciplinary research approaches not only improve diagnostic precision but also provide a robust foundation for applied research and encourage greater collaboration among researchers in virology, oncology, bioinformatics, and medical imaging fields.[26] To address specificity, we emphasize that these interdisciplinary approaches can lead to several tangible outcomes, such as: Development of AI-powered diagnostic tools for the early detection of EV-associated skin lesions using non-invasive image analysis, potentially enabling point-of-care screening in resource-limited settings.Creation of risk stratification models that combine HPV genotyping (e.g., HPV5, HPV8) with host genetic data to predict the likelihood of malignant transformation into cutaneous Squamous Cell Carcinoma (cSCC).Discovery of novel virological associations, such as previously unrecognized beta-HPV subtypes linked to aggressive EV phenotypes, through large-scale data mining and co-occurrence network analysis.Facilitation of international research consortia focused on rare genodermatoses, leveraging shared datasets and standardized AI frameworks to accelerate translational research. Development of AI-powered diagnostic tools for the early detection of EV-associated skin lesions using non-invasive image analysis, potentially enabling point-of-care screening in resource-limited settings. Development of AI-powered diagnostic tools for the early detection of EV-associated skin lesions using non-invasive image analysis, potentially enabling point-of-care screening in resource-limited settings. Creation of risk stratification models that combine HPV genotyping (e.g., HPV5, HPV8) with host genetic data to predict the likelihood of malignant transformation into cutaneous Squamous Cell Carcinoma (cSCC). Creation of risk stratification models that combine HPV genotyping (e.g., HPV5, HPV8) with host genetic data to predict the likelihood of malignant transformation into cutaneous Squamous Cell Carcinoma (cSCC). Discovery of novel virological associations, such as previously unrecognized beta-HPV subtypes linked to aggressive EV phenotypes, through large-scale data mining and co-occurrence network analysis. Discovery of novel virological associations, such as previously unrecognized beta-HPV subtypes linked to aggressive EV phenotypes, through large-scale data mining and co-occurrence network analysis. Facilitation of international research consortia focused on rare genodermatoses, leveraging shared datasets and standardized AI frameworks to accelerate translational research. Facilitation of international research consortia focused on rare genodermatoses, leveraging shared datasets and standardized AI frameworks to accelerate translational research. These outcomes are grounded in existing applications of AI and machine learning in oncology and virology, as cited in[21] and.[22] By adapting these proven methodologies to the unique context of EV—a rare disease with a well-defined viral and genetic etiology—we believe our recommendations offer a practical roadmap for future research with measurable impact. Research limitations and future directions While this study offers the first comprehensive bibliometric analysis of EV research over nearly a century, several limitations need to be considered. First, relying solely on the WOSCC might lead to underrepresentation of non-English publications and research from low- and middle-income countries, especially in regions like Africa, South Asia, and South America, where indexing rates are lower. This could create a geographic and language bias in the analysis of global research output. Future studies should include data from Scopus and PubMed to provide a more inclusive and balanced view of global EV research. Second, although the use of automated author disambiguation tools in the Bibliometrix R package helps, some author name variants—such as those caused by transliteration, name changes, or inconsistent initials—may still not be fully resolved. This could affect the accuracy of author-level metrics like citation counts and collaboration networks. Future research could incorporate manual curation or advanced machine learning techniques for better author identification. Third, including all document types—such as articles, reviews, letters, and conference abstracts—without weighing them differently may bias citation indicators, as reviews generally garner more citations than original research. However, because EV is a rare field, we prioritized inclusivity to capture all relevant scholarly contributions, including early case reports, which are vital to the field’s history. Future qualitative or systematic reviews should evaluate the methodological quality and clinical significance of the most cited papers to supplement this bibliometric overview. Lastly, although bibliometric analysis reveals publication and citation trends, it does not assess the clinical validity or therapeutic impact of the findings. Therefore, future work should combine bibliometric insights with clinical epidemiology studies to identify high-impact research areas, validate AI-based diagnostic models in real-world settings, and investigate the role of understudied beta-HPV genotypes in malignant transformation. Addressing these limitations will enhance our understanding of EV research and foster more equitable, collaborative, and translational progress in this rare but impactful genodermatosis. Authors’ contributions Farshid Danesh: concept, design, definition of intellectual content, literature search, data acquisition; Fatemeh Alinezhad Chamazcoti: data analysis, statistical analysis; Forough Rahimi: manuscript preparation, manuscript editing; Saeed Bakhtiari: manuscript review. Conflicts of interest There are no conflicts of interest.